Osteonecrosis of the jaw (ONJ) in renal cell cancer patients after treatment including zoledronic acid or denosumab

Support Care Cancer. 2014 Jul;22(7):1737-8. doi: 10.1007/s00520-014-2159-6. Epub 2014 Feb 26.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Bone Density Conservation Agents / therapeutic use*
  • Bone Neoplasms / secondary*
  • Bone Resorption / drug therapy*
  • Diphosphonates / therapeutic use*
  • Female
  • Humans
  • Imidazoles / therapeutic use*
  • Male
  • Neoplasms / pathology*

Substances

  • Antibodies, Monoclonal, Humanized
  • Bone Density Conservation Agents
  • Diphosphonates
  • Imidazoles